Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent vs Salbutamol and Ipratropium in COPD
NCT02182856Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1998
- Primary completion
- Jul 2000
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 4 trial of Combivent in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Feb 1998; status: completed.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02182856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182856.